MENU
+Compare
IPHA
Stock ticker: NASDAQ
AS OF
Jul 2 closing price
Price
$1.82
Change
-$0.03 (-1.62%)
Capitalization
165.36M

IPHA Innate Pharma SA Forecast, Technical & Fundamental Analysis

Innate Pharma SA is a clinical-stage biotechnology company... Show more

IPHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for IPHA with price predictions
Jul 03, 2025

IPHA in downward trend: 10-day moving average crossed below 50-day moving average on June 13, 2025

The 10-day moving average for IPHA crossed bearishly below the 50-day moving average on June 13, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 20 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 06, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on IPHA as a result. In of 113 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

IPHA moved below its 50-day moving average on June 10, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IPHA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for IPHA entered a downward trend on July 03, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where IPHA's RSI Oscillator exited the oversold zone, of 22 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 73 cases where IPHA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

IPHA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (16.103) is normal, around the industry mean (16.648). P/E Ratio (0.000) is within average values for comparable stocks, (58.447). IPHA's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.259). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (9.901) is also within normal values, averaging (268.529).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. IPHA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IPHA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
IPHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

IPHA is expected to report earnings to fall 73.33% to -7 cents per share on September 15

Innate Pharma SA IPHA Stock Earnings Reports
Q2'22
Est.
$-0.08
Q4'24
Beat
by $0.10
Q2'23
Beat
by $0.16
The last earnings report on March 27 showed earnings per share of -30 cents, beating the estimate of -40 cents. With 5.45K shares outstanding, the current market capitalization sits at 165.36M.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which focuses on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
117, Avenue de Luminy
Phone
+33 430303030
Employees
211
Web
https://www.innate-pharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUSDF0.90N/A
N/A
Perenti Global Ltd.
BKEAY1.63N/A
N/A
Bank of East Asia Limited
TNRSF18.36N/A
N/A
Tenaris S.A.
ENTBF0.07N/A
N/A
ENTHEON BIOMEDICAL CORP.
NGPHF0.06N/A
-1.36%
Northern Graphite Corp.

IPHA and Stocks

Correlation & Price change

A.I.dvisor tells us that IPHA and TECH have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IPHA and TECH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPHA
1D Price
Change %
IPHA100%
N/A
TECH - IPHA
29%
Poorly correlated
-0.08%
QSI - IPHA
27%
Poorly correlated
+8.08%
ENTA - IPHA
25%
Poorly correlated
-1.00%
NAUT - IPHA
24%
Poorly correlated
+4.73%
SVRA - IPHA
24%
Poorly correlated
+4.29%
More